Guillaume Chevalier is an Associate Director with over 27 years of experience in Safety Assessment, involved in development programs for pharmaceutical and chemical/agrochemical products with particular expertise in the areas of general and reproductive toxicology, carcinogenicity, multiple ROA, and species (NHPs inclusive). Guillaume is experienced in designing, overseeing, and managing non-clinical safety assessment programs for a range of modalities including small molecules and biologics for a broad array of therapeutic indications.
Lay Proper Toxicology Groundwork for a Successful Preclinical IND Submission
Amid the shifting sands of preclinical drug development, general toxicology research remains the cornerstone of a successful IND program. Your sprint to market requires a solid foundation of informed planning and forward thinking. This webinar delves into the factors to consider when you’re laying the groundwork for your product’s safety profile.
Watch Now